Related Experiment Video
Updated: Sep 4, 2025
04:50
Complete Laparoscopic Radical Resection of Perihilar Cholangiocarcinoma Type IIIb
Published on: January 17, 2025
399
Precision Medicine in Biliary Tract Cancer
Aaron J Scott1, Reya Sharman1, Rachna T Shroff1
1Division of Hematology and Oncology, University of Arizona Cancer Center, Tucson, AZ.
Summary
Precision medicine advances targeted therapies for advanced biliary tract cancers (BTCs). Molecular profiling identifies targetable abnormalities in up to 40% of BTCs, guiding personalized treatment strategies.
Area of Science:
- Oncology
- Genetics
- Precision Medicine
Background:
- Biliary tract cancers (BTCs) have a poor prognosis, but precision medicine is transforming treatment.
- Chronic inflammation is a key factor in BTC oncogenesis across subtypes.
- BTCs are molecularly heterogeneous, with up to 40% harboring targetable abnormalities.
Purpose of the Study:
- To review the current landscape of precision medicine in biliary tract cancers.
- To highlight the importance of molecular profiling for advanced BTC.
- To discuss emerging therapeutic strategies for BTC.
Main Methods:
- Review of current literature on precision medicine in BTC.
- Analysis of molecular profiling techniques including circulating tumor DNA, immunohistochemistry, and next-generation sequencing.
- Examination of National Comprehensive Cancer Network guidelines.
Main Results:
- Targeted therapies have improved the outlook for advanced BTC.
- Molecular profiling is recommended for all advanced BTC patients.
- Biomarker-driven management and molecular monitoring are expanding.
Conclusions:
- Precision medicine offers new hope for biliary tract cancer patients.
- Molecular characterization is crucial for identifying treatment targets.
- Combination therapies, including immune checkpoint inhibitors, show promise for non-targetable tumors.
Related Concept Videos
02:57Targeted Cancer Therapies
7.8K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.8K
02:50Combination Therapies and Personalized Medicine
5.1K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.1K